HSDT
Helius Medical Technologies Inc
$
6.035
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
6.035
Open
6.035
VWAP
6.04
Vol
1.30K
Mkt Cap
4.11M
Low
6.035
Amount
7.86K
EV/EBITDA(TTM)
--
Total Shares
2.96M
EV
3.00M
EV/OCF(TTM)
--
P/S(TTM)
0.08
Helius Medical Technologies, Inc. is a neurotechnology company. The Company is engaged in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS), is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy utilizes the PoNS device in conjunction with supervised therapeutic exercise. The PoNS Therapy consists of condition-specific exercises for movement control, including balance and gait training and breathing and awareness training, which are tailored to focus on the individual patient’s functional deficits.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
75.00K
-58.79%
--
--
110.00K
+115.69%
--
--
140.00K
-7.89%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Helius Medical Technologies, Inc. (HSDT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -97.20%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-97.20%
In Past 3 Month
2 Analyst Rating
2.73% Upside
Wall Street analysts forecast HSDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSDT is 6.20 USD with a low forecast of 2.90 USD and a high forecast of 9.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
2.73% Upside
Current: 6.035
Low
2.90
Averages
6.20
High
9.50
2.73% Upside
Current: 6.035
Low
2.90
Averages
6.20
High
9.50
Maxim Group
Anthony Vendetti
Strong Buy
to
Hold
Downgrades
n/a
2024-10-16
Reason
Maxim Group
Anthony Vendetti
Price Target
n/a
2024-10-16
Downgrades
Strong Buy
to
Hold
Reason
Maxim analyst Anthony Vendetti downgraded Helius Medical to Hold from Buy.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Helius Medical Technologies Inc (HSDT.O) is -0.03, compared to its 5-year average forward P/E of -2.42. For a more detailed relative valuation and DCF analysis to assess Helius Medical Technologies Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-2.42
Current PE
-0.03
Overvalued PE
3.75
Undervalued PE
-8.58
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
10.82
Current PS
8.91
Overvalued PS
28.92
Undervalued PS
-7.28
Financials
Annual
Quarterly
FY2025Q1
YoY :
-63.70%
49.00K
Total Revenue
FY2025Q1
YoY :
+17.42%
-4.01M
Operating Profit
FY2025Q1
YoY :
+52.54%
-3.84M
Net Income after Tax
FY2025Q1
YoY :
-83.50%
-380.94
EPS - Diluted
FY2025Q1
YoY :
+17.63%
-3.54M
Free Cash Flow
FY2025Q1
YoY :
-4071.35%
-146.94
Gross Profit Margin - %
FY2025Q1
YoY :
+73.96%
-2.67K
FCF Margin - %
FY2025Q1
YoY :
+320.27%
-7.83K
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
HSDT News & Events
Events Timeline
2025-07-21 (ET)
2025-07-21
07:03:12
Helius Medical announces outcome of PoNS Stroke Registrational Program
2025-07-09 (ET)
2025-07-09
08:37:18
Helius Medical receives compliance letter from Nasdaq
2025-06-27 (ET)
2025-06-27
08:31:49
Helius Medical announces 1-for-50 reverse stock split
Sign Up For More Events
Sign Up For More Events
News
4.5
07-21TipRanksMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
9.0
07-21BenzingaHelius Medical Technologies (HSDT) Stock Is Surging Today: What's Happening?
9.0
07-21TipRanksWhy Is Helius Medical Technologies Stock (HSDT) Up 70% Today?
Sign Up For More News
People Also Watch
NVVE
Nuvve Holding Corp
0.590
USD
-1.34%
SYTA
Siyata Mobile Inc
3.516
USD
-2.33%
VERO
Venus Concept Inc
2.440
USD
0.00%
DRMA
Dermata Therapeutics Inc
6.445
USD
0.00%
TIVC
Tivic Health Systems Inc
3.510
USD
0.00%
PCSA
Processa Pharmaceuticals Inc
0.224
USD
-2.19%
PRFX
PainReform Ltd
1.450
USD
0.00%
ASST
Asset Entities Inc
4.930
USD
+8.47%
AUUD
Auddia Inc
2.460
USD
-15.75%
FAQ
What is Helius Medical Technologies Inc (HSDT) stock price today?
The current price of HSDT is 6.035 USD — it has increased 0 % in the last trading day.
What is Helius Medical Technologies Inc (HSDT)'s business?
What is the price predicton of HSDT Stock?
What is Helius Medical Technologies Inc (HSDT)'s revenue for the last quarter?
What is Helius Medical Technologies Inc (HSDT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Helius Medical Technologies Inc (HSDT)'s fundamentals?
How many employees does Helius Medical Technologies Inc (HSDT). have?